Clinical Trial Update: A Study to Evaluate Real-world Brolucizumab Effectiveness and Safety in Japanese Patients With Neovascular Age-related Macular Degeneration (nAMD)

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating the real-world effectiveness and safety of brolucizumab in Japanese patients with neovas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• BEOVU (BROLUCIZUMAB)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Neovascular Age-Related Macular Degeneration | Status: COMPLETED